4-Chloro-7-Methoxyquinoline-6-Carboxamide CAS 417721-36-9 Ịdị ọcha>98.5% (HPLC) Ụlọ ọrụ etiti Lenvatinib Mesylate

Nkọwa dị mkpirikpi:

Aha: 4-Chloro-7-Methoxyquinoline-6-Carboxamide

CAS: 417721-36-9

Dị ọcha:> 98.5% (HPLC)

Ọdịdị: Gbanyụọ-Ọcha ka ntụ ntụ edo edo dị ọkụ

Ọkara nke Lenvatinib Mesylate CAS 857890-39-2

Ogo dị elu, mmepụta azụmahịa

E-Mail: alvin@ruifuchem.com


Nkọwa ngwaahịa

Ngwaahịa ndị emetụtara

Mkpado ngwaahịa

Nkọwa:

Njirimara kemịkalụ:

Aha Chemical 4-Chloro-7-Methoxyquinoline-6-Carboxamide
Ụdị okwu 4-Chloro-7-Methoxy-6-Quinolinecarboxamide;Lenvatinib adịghị ọcha 12;Lenvatinib adịghị ọcha B;Lenvatinib adịghị ọcha LFS-B
Nọmba CAS 417721-36-9
Nọmba CAT RF-PI1971
Ọnọdụ Ahịa N'ahịa, Ikike Mmepụta 50MT/Afọ
Usoro ihe omimi C11H9ClN2O2
Ibu molekụla 236.65
Ebe Na-agbaze > 205 ℃ (Dec.)
Njupụta 1.380±0.060 g/cm3
Ụdị Ruifu Chemical

Nkọwapụta:

Ihe Nkọwapụta
Ọdịdị Gbanyụọ-Ọcha ka ntụ ntụ edo edo dị ọkụ
Ụzọ ịdị ọcha / nyocha > 98.5% (HPLC)
Ọnwụ na ihicha <0.50%
Ihe fọdụrụ na mgbanye <0.50%
Mgbakọta adịghị ọcha <1.50%
Ọnụ ego nke Proton NMR Spectrum Dabara na Ọdịdị
Nlele ọkọlọtọ Standardkpụrụ ụlọ ọrụ
Ojiji Ndị etiti Lenvatinib Mesylate (CAS: 857890-39-2)

Ngwungwu & Nchekwa:

ngwugwu: Kalama, Aluminom foil bag, 25kg / Cardboard Drum, ma ọ bụ dị ka ndị ahịa chọrọ

Ọnọdụ Nchekwa:Na-echekwa n'ime akpa ndị a kpuchiri ekpuchi na ebe dị jụụ na nke kpọrọ nkụ;Chebe site na ìhè na mmiri mmiri

Uru:

1

Ajụjụ:

Ngwa:

4-Chloro-7-Methoxyquinoline-6-Carboxamide (CAS: 417721-36-9) ka a na-ejikarị dị ka etiti nke Lenvatinib Mesylate (CAS: 857890-39-2).Mepụtara Eisai Inc., lenvatinib mesylate bụ vaskụla endothelial growth factor receptor (VEGF) inhibitor nke nwere ọrụ megide VEGF subtypes 1, 2, na 3 ma kwadoro ya na FDA na 2015 maka ọgwụgwọ ọrịa cancer thyroid dị iche iche nke bụ na mpaghara. na-emegharị ugboro ugboro, metastatic, ma ọ bụ na-aga n'ihu ma ọ naghị anabata ọgwụgwọ iodine redioaktivu.Na Mee 2016, FDA kwadoro ọgwụ ahụ dị ka ọgwụgwọ ngwakọta na everolimus maka ọgwụgwọ nke carcinoma renal renal cell.N'ihi na VEGF (na fibroblast growth factor receptors, nke a maara dị ka FGFRs) na-eche na ha na-ekere òkè na ụzọ mgbaàmà nke obi, VEGF2R na mgbochi FGFR na-eche na ọ bụ usoro n'azụ isi mmetụta nke lenvatinib mesylate, nke bụ ọbara mgbali elu.

Dee ozi gị ebe a ziga anyị ya